info:eu-repo/semantics/article
Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
Fecha
2019-03-04Registro en:
Ridruejo, Ezequiel; Soza, Alejandro M. D.; Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?; John Wiley & Sons Inc; Clinical Liver Disease; 13; 2; 4-3-2019; 43-45
2046-2484
CONICET Digital
CONICET
Autor
Ridruejo, Ezequiel
Soza, Alejandro M. D.
Resumen
Hepatitis C virus (HCV) infection is a global health concern with an estimated worldwide disease prevalence rate of 1%, meaning 71 million individuals are infected.1 In the United States, the estimated prevalence rate is 0.7%, or 7 million individuals.1 Specifically in Latin America, estimations suggest that only 25% of individuals with suspected HCV infection have been diagnosed, and only 4% received treatment.2 Recent availability in this region of directacting antivirals (DAAs), which are safer and more effective than the interferon-based therapies, may influence treatment paradigms at country levels.